Cabaletta Bio, Inc. - Common Stock (NQ:CABA)

2.080 +0.080 (+4.00%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cabaletta Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 25, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 08, 2022

Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 05, 2022

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock rose 14.5% to $0.53 during Tuesday's after-market session. The company's market cap stands at $14.0 million.

Via Benzinga

NASDAQ:CABA Long Term Investor Alert: Investigation over Potential Wrongdoing at Cabaletta Bio, Inc. ↗

June 17, 2022

San Diego, CA -- (SBWIRE) -- 06/17/2022 -- Certain directors of Cabaletta Bio, Inc. are under investigation over potential breaches of fiduciary duties.

Via SBWire

Cabaletta Bio's Updated Interim DSG3-CAART Data Fails To Cheer Investors ↗

May 18, 2022

Via Benzinga

Recap: Cabaletta Bio Q4 Earnings ↗

March 17, 2022

Cabaletta Bio (NASDAQ:CABA) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

Why Did Mizuho Cut Price Target On This CAR-T Stock, But Remain Bullish ↗

May 25, 2022

Mizuho met Cabaletta Bio Inc (NASDAQ: CABA) management team after last week's data release at ASGCT.

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation ↗

May 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More ↗

May 16, 2022

Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from...

Via Benzinga

73 Biggest Movers From Yesterday ↗

May 17, 2022

Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 29, 2022

Gainers Ocular Therapeutix (NASDAQ:OCUL) shares moved upwards by 12.3% to $4.01 during Friday's after-market session. The company's market cap stands at $307.7 million.

Via Benzinga

80 Biggest Movers From Yesterday ↗

May 04, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to...

Via Benzinga

Deadline Today Reminder: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to Contact the Firm

April 29, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Deadline Today Alert: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to Contact the Firm

April 29, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Deadline Tomorrow Reminder: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to Contact the Firm

April 28, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

CABALETTA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Cabaletta Bio, Inc. and Encourages Investors to Contact the Firm

April 27, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

60 Biggest Movers From Yesterday ↗

April 26, 2022

Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 25, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 25, 2022

Via Benzinga

Bronstein, Gewirtz & Grossman, LLC Reminds Cabaletta Bio, Inc. (CABA) Investors of Class Action Deadline and Encourages Investors to Contact the Firm

April 25, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

CABA SHAREHOLDER ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Cabaletta Bio, Inc. Investors to Secure Counsel Before Important April 29 Deadline in Securities Class Action - CABA

April 22, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 22, 2022

Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) stock moved upwards by 16.8% to $1.32 during Friday's after-market session. The company's market cap stands at $37.0 million.

Via Benzinga

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CABA

April 15, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CABA

April 10, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 04, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CABA

March 30, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

CABA Stock Investigation: Robbins LLP Investigates Cabaletta Bio, Inc. (CABA) on Behalf of Shareholders

March 18, 2022

From Robbins LLP

Via Business Wire

Cabaletta Bio, Inc. (NASDAQ:CABA) Investor Notice: Lawsuit Alleges Securities Laws Violations ↗

March 18, 2022

San Diego, CA -- (SBWIRE) -- 03/18/2022 -- An investor, who purchased shares of Cabaletta Bio, Inc. (NASDAQ:CABA), filed a lawsuit over alleged violations of Federal Securities Laws by Cabaletta Bio,...

Via SBWire

10 Biggest Price Target Changes For Friday ↗

March 18, 2022

Keybanc cut the price target on AMETEK, Inc. (NYSE: AME) from $160 to $155. AMETEK shares rose 1% to close at $132.75 on Thursday.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.